Search research articles
Contact Us
Filters
Showing results (41-50 of 90) with videos related to
Page
of 9
Sort By:
Nucleosides, Nucleotides & Nucleic Acids
|
September 21, 2001
Pharmacokinetics of salicylate ester prodrugs of cyclic HPMPC in dogs
R Oliyai, M N Arimilli, R J Jones, et al.
International Journal of Pharmaceutics
|
March 4, 1999
Enhanced chemical stability of the intracellular prodrug, 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine, relative to its parent compound, cidofovir
R Oliyai, W A Lee, G C Visor, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
September 1, 1996
Extracorporeal life support for cardiovascular support in adults
S Kolla, W A Lee, R B Hirschl, et al.
Pharmaceutical Research
|
May 1, 1994
The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer
W A Lee, R D Ennis, J P Longenecker, et al.
Experimental Brain Research
|
January 24, 2003
Effects of predictive mechanisms on head stability during forward trunk perturbation
M Simoneau, S W Tinker, T C Hain, et al.
Pathology, Research and Practice
|
December 22, 1999
p53, p16 and RB expression in adenosquamous and squamous cell carcinomas of the stomach
W A Lee, D K Woo, Y I Kim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1996
Pharmacokinetics of cidofovir in monkeys. Evidence for a prolonged elimination phase representing phosphorylated drug
K C Cundy, Z H Li, M J Hitchcock, et al.
Paraplegia
|
November 1, 1975
A method of quantitating injury inflicted in acute spinal cord studies
H B Daniell, W W Francis, W A Lee, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
|
February 24, 2001
Does complete aneurysm exclusion ensure long-term success after endovascular repair?
W A Lee, Y G Wolf, T J Fogarty, et al.
Journal of Pharmaceutical Sciences
|
August 1, 1991
Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio
W A Lee, B A Narog, T W Patapoff, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 90) with videos related to
Sort By:
Page
of 9
Nucleosides, Nucleotides & Nucleic Acids
|
September 21, 2001
Pharmacokinetics of salicylate ester prodrugs of cyclic HPMPC in dogs
R Oliyai, M N Arimilli, R J Jones, et al.
International Journal of Pharmaceutics
|
March 4, 1999
Enhanced chemical stability of the intracellular prodrug, 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine, relative to its parent compound, cidofovir
R Oliyai, W A Lee, G C Visor, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
September 1, 1996
Extracorporeal life support for cardiovascular support in adults
S Kolla, W A Lee, R B Hirschl, et al.
Pharmaceutical Research
|
May 1, 1994
The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer
W A Lee, R D Ennis, J P Longenecker, et al.
Experimental Brain Research
|
January 24, 2003
Effects of predictive mechanisms on head stability during forward trunk perturbation
M Simoneau, S W Tinker, T C Hain, et al.
Pathology, Research and Practice
|
December 22, 1999
p53, p16 and RB expression in adenosquamous and squamous cell carcinomas of the stomach
W A Lee, D K Woo, Y I Kim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1996
Pharmacokinetics of cidofovir in monkeys. Evidence for a prolonged elimination phase representing phosphorylated drug
K C Cundy, Z H Li, M J Hitchcock, et al.
Paraplegia
|
November 1, 1975
A method of quantitating injury inflicted in acute spinal cord studies
H B Daniell, W W Francis, W A Lee, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
|
February 24, 2001
Does complete aneurysm exclusion ensure long-term success after endovascular repair?
W A Lee, Y G Wolf, T J Fogarty, et al.
Journal of Pharmaceutical Sciences
|
August 1, 1991
Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio
W A Lee, B A Narog, T W Patapoff, et al.
Page
of 9